All In MedTech

FDA Clearance Tracker · P100049-S002

LINX REFLUX MANAGEMENT SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 22, 2012 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 22, 2012

Approved

Time to decision

60 days

Received Apr 23, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100049-S002
Device name
LINX REFLUX MANAGEMENT SYSTEM
Applicant
Torax Medical
Applicant location
Cincinnati, OH
Received
Apr 23, 2012
Decided
Jun 22, 2012
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P100049

Device type

Device class
Class III

Every decision under product code LEI

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Torax Medical

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.